BIO-TECHNE Corp Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, filed on October 25, 2024, reports on the Annual Meeting of Shareholders and references financial results for the quarter ended September 30, 2024. The Company, BIO-TECHNE Corporation, is incorporated in Minnesota and trades on NASDAQ under the symbol TECH.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained in the press release attached as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes and Corporate Actions
- Dividend Announcement: The Company announced a cash dividend via a press release dated October 30, 2024 (Exhibit 99.2). The specific dividend amount is not stated in the filing text.
- Shareholder Voting: A quorum was present with 148,168,864 shares represented (93.39% of outstanding shares).
Outlook, Risks, and Management Commentary
Management commentary and outlook details are located in the attached press release (Exhibit 99.1) and are not present in the body of this Form 8-K. The filing notes that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 for specific Q3 2024 revenue, earnings, and margin figures.
- Review Exhibit 99.2 for the exact cash dividend amount and payment date.
- Verify the election results for the nine directors, noting that all nominees were elected.
- Confirm the ratification of KPMG LLP as the independent auditor for the fiscal year ending June 30, 2025.